loading
前日終値:
$5.71
開ける:
$5.7
24時間の取引高:
759.46K
Relative Volume:
0.17
時価総額:
$1.88B
収益:
$493.67M
当期純損益:
$-104.69M
株価収益率:
-16.54
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
-1.82%
1か月 パフォーマンス:
-9.56%
6か月 パフォーマンス:
-42.54%
1年 パフォーマンス:
-43.00%
1日の値動き範囲:
Value
$5.51
$5.71
1週間の範囲:
Value
$5.51
$5.8199
52週間の値動き範囲:
Value
$5.51
$12.65

Amicus Therapeutics Inc Stock (FOLD) Company Profile

Name
名前
Amicus Therapeutics Inc
Name
セクター
Healthcare (1171)
Name
電話
(609) 662-2000
Name
住所
47 HULFISH STREET, PRINCETON, NJ
Name
職員
499
Name
Twitter
@amicusrx1
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
FOLD's Discussions on Twitter

FOLD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FOLD
Amicus Therapeutics Inc
5.63 1.88B 493.67M -104.69M -31.51M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.72 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
519.45 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.47 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
562.00 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.63 28.51B 3.81B -644.79M -669.77M -6.24

Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-13 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-09-06 開始されました Jefferies Buy
2024-05-30 開始されました Wells Fargo Overweight
2024-05-14 アップグレード Guggenheim Neutral → Buy
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-09-09 開始されました Morgan Stanley Equal-Weight
2022-04-13 再開されました Goldman Neutral
2022-01-14 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-15 アップグレード Stifel Hold → Buy
2021-09-30 アップグレード JP Morgan Neutral → Overweight
2021-07-19 再開されました BTIG Research Buy
2021-05-27 開始されました Needham Hold
2021-05-21 開始されました UBS Buy
2021-04-14 アップグレード Cantor Fitzgerald Neutral → Overweight
2021-03-02 開始されました Stifel Hold
2021-02-12 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-02-12 ダウングレード JP Morgan Overweight → Neutral
2020-12-28 再開されました Cantor Fitzgerald Overweight
2020-12-10 ダウングレード Citigroup Buy → Neutral
2020-11-11 開始されました Berenberg Hold
2020-06-17 開始されました BTIG Research Buy
2020-02-04 再開されました Cantor Fitzgerald Overweight
2019-11-12 繰り返されました H.C. Wainwright Buy
2019-06-17 開始されました H.C. Wainwright Buy
2019-06-05 繰り返されました Cantor Fitzgerald Overweight
2019-04-05 開始されました Janney Buy
2019-01-30 開始されました Cantor Fitzgerald Overweight
2018-10-29 開始されました Citigroup Neutral
2018-08-17 ダウングレード Chardan Capital Markets Buy → Neutral
2017-10-06 再開されました Goldman Neutral
2017-09-13 繰り返されました Chardan Capital Markets Buy
2017-08-10 繰り返されました Chardan Capital Markets Buy
2017-01-24 アップグレード Robert W. Baird Neutral → Outperform
2016-05-18 開始されました BofA/Merrill Buy
2016-04-14 開始されました Robert W. Baird Neutral
2016-04-12 繰り返されました Chardan Capital Markets Buy
2015-09-16 ダウングレード Chardan Capital Markets Buy → Neutral
2015-06-16 繰り返されました Chardan Capital Markets Buy
すべてを表示

Amicus Therapeutics Inc (FOLD) 最新ニュース

pulisher
Jun 18, 2025

When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Turn A Profit? - simplywall.st

Jun 18, 2025
pulisher
Jun 17, 2025

Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week LowTime to Sell? - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Amicus Therapeutics stock hits 52-week low at 5.79 USD By Investing.com - Investing.com Canada

Jun 17, 2025
pulisher
Jun 16, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives $16.22 Average Price Target from Analysts - MarketBeat

Jun 16, 2025
pulisher
Jun 14, 2025

(FOLD) Technical Data - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 14, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Wedge Capital Management L L P NC - MarketBeat

Jun 14, 2025
pulisher
Jun 12, 2025

Amicus Therapeutics: Opportunity Awaits In This Beaten Down Pharma (NASDAQ:FOLD) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 10, 2025

Amicus Therapeutics at Goldman Sachs Conference: Strategic Insights Unveiled By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight - Yahoo Finance

Jun 10, 2025
pulisher
Jun 09, 2025

Zacks Research Issues Pessimistic Outlook for FOLD Earnings - MarketBeat

Jun 09, 2025
pulisher
Jun 05, 2025

Two Sigma Investments LP Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 05, 2025
pulisher
Jun 04, 2025

Pompe Disease Therapeutic Market Deep Research Report with - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Buys 44,449 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 04, 2025
pulisher
Jun 03, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

New Strong Sell Stocks for June 3rd - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Amicus (FOLD) Reports Positive Findings from PROPEL Study in Pompe Disease | FOLD Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Clinical Data Reveals Treatment Advantages: 77% of Pompe Disease Patients Show Improvement with New Therapy - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Two Sigma Advisers LP Acquires 52,000 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Cetera Investment Advisers Takes Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

How to Take Advantage of moves in (FOLD) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
May 31, 2025

Man Group plc Decreases Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 | FOLD Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Rare Disease Leader Amicus Therapeutics to Present Latest Updates at Major Healthcare Conferences - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Has $4.31 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

May 30, 2025
pulisher
May 30, 2025

Voloridge Investment Management LLC Sells 397,497 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 30, 2025
pulisher
May 28, 2025

Squarepoint Ops LLC Purchases 753,060 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Neo Ivy Capital Management Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Woodline Partners LP Sells 726,952 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Ameriprise Financial Inc. - Defense World

May 27, 2025
pulisher
May 26, 2025

Pompe Disease Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025
pulisher
May 26, 2025

Teza Capital Management LLC Sells 68,066 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Nuveen Asset Management LLC Purchases 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025
pulisher
May 25, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 25, 2025
pulisher
May 25, 2025

297,830 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Sovereign s Capital Management LLC - MarketBeat

May 25, 2025
pulisher
May 24, 2025

Vestal Point Capital LP Acquires New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 24, 2025
pulisher
May 23, 2025

Deutsche Bank AG Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 23, 2025
pulisher
May 21, 2025

Rafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 21, 2025

Amicus Therapeutics Inc (FOLD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Amicus Therapeutics Inc (FOLD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Campbell Bradley L
President and CEO
Feb 19 '25
Sale
10.00
400
4,000
1,150,657
$20.36
price down icon 1.81%
$35.79
price down icon 0.98%
$20.61
price down icon 0.76%
$105.30
price down icon 0.50%
$103.74
price down icon 1.27%
biotechnology ONC
$266.08
price down icon 0.06%
大文字化:     |  ボリューム (24 時間):